Therapy (HCV)
"Interferon as Treatment for Acute Hepatitis C: A Meta-Analysis."
Published in Hepatitis Weekly, August 5th, 1996
According to the authors' abstract of an article published in Digestive Diseases and Sciences, "The efficacy of short-course (three months), low-dose (3 million units three times a week) interferon as treatment for acute hepatitis C was evaluated in a meta-analysis of controlled trials. Nine studies (five randomized and four nonrandomized) found by MEDLINE search were eligible for analysis. The outcomes assessed were the rate of patients with normal serum aminotransferases (all trials) and without HCV RNA in blood (five trials) after posttreatment follow-up. Eight trials compared interferon to no treatment, and one compared different schedules of interferon. The methodological quality...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (1996-08-05)
More Articles from Hepatitis Weekly
- Therapy (HCV)
Gradually Reducing IFN Results in Better HCV Treatment - Diagnostics (HBV)
Anti-HBc is Marker of HBV Infection in HIV+ - Immunology
Plasmid Constructs with HCV Core Protein is Potential Therapy - Industry News (Patents and Technologies)
U.S. Patent on 3TC Awarded to Emory University - Risk Factors
Low Risk for Hepatitis Among Child Care Providers Reported - Testing (HCV)
HCV Test Needed in Those with Neuropathy/Mixed Cryoglobulinemia - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
